Symptom trajectories in patients with panic disorder in a primary care intervention: Results from a randomized controlled trial (PARADISE).


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
09 05 2019
Historique:
received: 25 01 2019
accepted: 24 04 2019
entrez: 11 5 2019
pubmed: 11 5 2019
medline: 21 10 2020
Statut: epublish

Résumé

This analysis aims to identify and characterize symptom trajectories in primary care patients with panic disorder with/without agoraphobia (PD/AG) who participated in a primary care team based training involving elements of cognitive behavioural therapy (CBT). Growth Mixture Modeling was used to identify different latent classes of change in patients with PD/AG (N = 176) who underwent treatment including CBT elements. We identified three patient classes with distinct similar trajectories. Class 1 (n = 58, mean age: 46.2 years ± 13.4 years, 81% women) consisted of patients with an initially high symptom burden, but symptoms declined constantly over the intervention period. Symptoms of patients in class 2 (n = 89, mean age: 44.2 years ± 14.5 years, 67.4% women) declined rapidly at the beginning, then patients went into a plateau-phase. The third class (n = 29, mean age: 47.0 years ± 12.4 years, 65.5% women) was characterized by an unstable course and had the worse outcome. Our findings show that only a minority did not respond to the treatment. To identify this minority and refer to a specialist would help patients to get intensive care in time.

Identifiants

pubmed: 31073189
doi: 10.1038/s41598-019-43487-x
pii: 10.1038/s41598-019-43487-x
pmc: PMC6509250
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7170

Références

Behav Res Ther. 1993 Jan;31(1):1-8
pubmed: 8093337
Annu Rev Clin Psychol. 2007;3:1-27
pubmed: 17716046
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Trials. 2014 Apr 06;15:112
pubmed: 24708672
Health Aff (Millwood). 2001 Nov-Dec;20(6):64-78
pubmed: 11816692
J Consult Clin Psychol. 1997 Aug;65(4):673-85
pubmed: 9256569
Psychother Psychosom. 2013;82(1):20-34
pubmed: 23147126
Dtsch Arztebl Int. 2019 Mar 8;116(10):159-166
pubmed: 30995952
Eur Neuropsychopharmacol. 2011 Sep;21(9):655-79
pubmed: 21896369
Ann Intern Med. 2007 Mar 6;146(5):317-25
pubmed: 17339617
J Consult Clin Psychol. 2005 Oct;73(5):904-13
pubmed: 16287390
Arch Gen Psychiatry. 1998 Apr;55(4):334-43
pubmed: 9554429
J Affect Disord. 2009 Jan;112(1-3):92-101
pubmed: 18486238
J Affect Disord. 2005 Dec;89(1-3):137-46
pubmed: 16274750
Annu Rev Clin Psychol. 2010;6:109-38
pubmed: 20192788
J Psychiatr Res. 2011 Feb;45(2):262-8
pubmed: 20609450
J Clin Psychiatry. 2008 Apr;69(4):621-32
pubmed: 18363421
Z Evid Fortbild Qual Gesundhwes. 2018 Apr;131-132:28-37
pubmed: 29544715
J Clin Psychiatry. 2008 Mar;69(3):418-24
pubmed: 18278989
Depress Anxiety. 2006;23(4):245-9
pubmed: 16688739
J Consult Clin Psychol. 2014 Apr;82(2):287-97
pubmed: 24447004

Auteurs

Karoline Lukaschek (K)

Institute of General Practice and Family Medicine, University Hospital of Ludwig-Maximilians-University Munich, Pettenkoferstr. 10, D-80336, Munich, Germany.

Thomas S Hiller (TS)

Institute of General Practice and Family Medicine, Jena University Hospital, Bachstrasse 18, D-07743, Jena, Germany.

Ulrike Schumacher (U)

Centre for Clinical Studies, Jena University Hospital, Jena, Salvador-Allende-Platz 27, D-07747, Jena, Germany.

Tobias Teismann (T)

Mental Health Research and Treatment Center, Ruhr-Universität Bochum, Massenbergstr. 11, D-44787, Bochum, Germany.

Jörg Breitbart (J)

Institute of General Practice and Family Medicine, Jena University Hospital, Bachstrasse 18, D-07743, Jena, Germany.

Christian Brettschneider (C)

Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246, Hamburg, Germany.

Hans-Helmut König (HH)

Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246, Hamburg, Germany.

Jürgen Margraf (J)

Mental Health Research and Treatment Center, Ruhr-Universität Bochum, Massenbergstr. 11, D-44787, Bochum, Germany.

Jochen Gensichen (J)

Institute of General Practice and Family Medicine, University Hospital of Ludwig-Maximilians-University Munich, Pettenkoferstr. 10, D-80336, Munich, Germany. jochen.gensichen@med.uni-muenchen.de.
Institute of General Practice and Family Medicine, Jena University Hospital, Bachstrasse 18, D-07743, Jena, Germany. jochen.gensichen@med.uni-muenchen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH